Desiree Abdurrachim
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool.
Journal: JHEP reports : innovation in hepatology
Published: September 26, 2025
AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models.
Journal: Nature communications
Published: May 28, 2025
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease.
Journal: Hepatology communications
Published: September 05, 2024
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.
Journal: Journal of hepatology
Published: July 22, 2024
Leukotriene B4 receptor 1 (BLT1) does not mediate disease progression in a mouse model of liver fibrosis.
Journal: The Biochemical journal
Published: October 03, 2023
Dexamethasone inhibits regeneration and causes ventricular aneurysm in the neonatal porcine heart after myocardial infarction.
Journal: Journal of molecular and cellular cardiology
Published: November 09, 2019
Single dose of empagliflozin increases in vivo cardiac energy status in diabetic db/db mice.
Journal: Cardiovascular research
Published: September 05, 2018
Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized 13 C pyruvate, butyrate and acetoacetate probes.
Journal: Diabetes, obesity & metabolism
Published: September 04, 2018
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13 C magnetic resonance spectroscopy study.
Journal: Diabetes, obesity & metabolism
Published: August 01, 2018
Last Updated: 09/26/2026